10/21/2011: Addendum A change

Please see Dr. Iafrate’s official announcement regarding our recent change to Addendum A at:

/docs/addaannounce.pdf

IRB-01 recently added a new column on Addendum A to have investigators indicate what study activities they are engaging in. As part of this change, IRB-01 is also expecting investigators to list anyone who is engaging in the research by conducting any of the following activities:

  • Interacts or intervenes directly with subjects
  • Performs any study related activities but does not interact directly with study subjects
  • Obtains informed consent
  • Access or obtains, for research purposes, any PHI from paper or electronic medical records (e.g. EPIC)
  • Enteres research related orders into EPIC for subsequent study physician or provider’s electronic signature approval
  • Evaluates any adverse events, unanticipated events, and protocol deviations.

Researchers will be required to use this newest Addendum A on all future submissions on December 1st, 2011:

  • New studies.
  • Your next Continuing Review. New signatures are only required if you are adding previously unlisted investigators.
  • Any revision that affects Addendum A. New signatures are only required if you are adding previously unlisted investigators.

Please read Dr. Iafrate’s announcement for further details: /docs/addaannounce.pdf